- Asked by: Rhoda Grant, MSP for Highlands and Islands, Scottish Labour
-
Date lodged: Thursday, 27 January 2011
-
Current Status:
Answered by Nicola Sturgeon on 7 February 2011
To ask the Scottish Executive whether the target to reduce non-attendance at a first outpatient appointment has been achieved.
Answer
The target to reduce first outpatient appointment did not attends (DNA) to 9.2% was due to be delivered by NHSScotland on 31 March 2010. Published figures show that for the quarter ending 31 March 2010 the DNA rate was 10.5%.
This is disappointing particularly in the current economic climate where it is even more vital that NHS boards reduce waste in their budgets. It is every patient''s responsibility to keep their appointment, but we recognise that the NHS has to be flexible in helping make appointments convenient for patients.
That is why the Scottish Government has given the NHS in Scotland a three per cent target for efficiency savings and all NHS boards are working on implementing policies to reduce missed appointments. This includes text and phone reminders, more choice over the time of an appointment and a poster campaign reminding patients of their responsibility in using NHS services. The Health Delivery Directorate Improvement and Support Team will continue to work with boards and ensure that good practice is identified and shared across Scotland.
- Asked by: Rhoda Grant, MSP for Highlands and Islands, Scottish Labour
-
Date lodged: Thursday, 27 January 2011
-
Current Status:
Answered by Nicola Sturgeon on 7 February 2011
To ask the Scottish Executive for what reason it did not take part in the study by the International Cancer Benchmarking Partnership, published in December 2010, into gaps in cancer survival rates between the United Kingdom and other developed countries.
Answer
Scotland is not taking part in this particular study as it already takes part in a number of other similar projects and regularly contributes to a study comparing survival rates in European countries (EUROCARE).
Furthermore, the Scottish Government is investing resources in the development of quality performance indicators and prospective audit data for cancer, as well as continuing to invest in prevention, early detection and better treatment to improving cancer survival rates.
- Asked by: Rhoda Grant, MSP for Highlands and Islands, Scottish Labour
-
Date lodged: Thursday, 27 January 2011
-
Current Status:
Answered by Nicola Sturgeon on 7 February 2011
To ask the Scottish Executive what the survival rate was for ovarian cancer in the periods (a) 1995 to 1999, (b) 2000 to 2002 and (c) 2005 to 2007, broken down by NHS board, and how this compared with the rates in (i) England, (ii) Wales and (iii) Northern Ireland.
Answer
Comparative survival for ovarian cancer within the United Kingdom is shown in the following table. It is important to note that survival depends on many factors, including data quality, characteristics of the patients and their tumours (case-mix), and health service factors. Survival estimates are also subject to random variation, especially when based on relatively small numbers of patients.
Cancer of the Ovary (ICD-10 C56, C57.0-C57.4)
Relative Survival1 (%) at 1 and 5 Years Following Diagnosis for those Diagnosed Aged 15 to 99 in 1995 to 1999, 2000 to 2002 and 2005 to 20072
| Country/Region | Diagnosed 1995 to 1999 | Diagnosed 2000 to 2002 | Diagnosed 2005 to 2007 |
| 1 Year | 5 Year | 1 Year | 5 Year | 1 Year |
| Scotland | 66.2 | 41.3 | 66.1 | 39.1 | 72.0 |
| NHS Board Areas3 | | | | | |
| Ayrshire and Arran | 65.0 | 43.2 | 55.0 | 31.4 | 71.7 |
| Borders | 60.9 | 35.6 | 49.5 | 41.5 | 78.5 |
| Dumfries and Galloway | 71.1 | 36.0 | 71.9 | 31.3 | 68.2 |
| Fife | 66.7 | 41.8 | 82.0 | 49.7 | 67.8 |
| Forth Valley | 59.0 | 34.6 | 74.9 | 41.1 | 77.3 |
| Grampian | 73.5 | 46.8 | 65.4 | 43.2 | 74.9 |
| Greater Glasgow and Clyde | 68.3 | 43.0 | 64.1 | 36.9 | 64.5 |
| Highland and Argyll | 62.5 | 35.6 | 62.4 | 34.0 | 82.7 |
| Lanarkshire | 63.8 | 39.2 | 64.0 | 35.0 | 74.5 |
| Lothian | 63.4 | 42.2 | 68.4 | 36.7 | 71.3 |
| Tayside | 66.7 | 42.8 | 67.7 | 46.4 | 75.1 |
| England | 65.4 | 38.8 | 67.0 | 40.2 | 70.6 |
| Wales | 60.6 | 35.4 | 63.9 | 38.9 | 66.1 |
| Great Britain | 65.2 | 38.8 | 66.7 | 40.0 | 70.5 |
| Northern Ireland | 67.5 | 43.9 | 68.9 | 45.2 | 68.0 |
| United Kingdom | 65.2 | 39.0 | 66.8 | 40.2 | 70.4 |
Source: UK Cancer Information Service of the National Cancer Intelligence Network.
Notes:
1 The relative survival estimates shown above are adjusted for background mortality in each of the UK countries but not for differences in overall life expectancy in the NHS boards in Scotland (because life tables for NHS boards are not readily available). The survival estimates are not standardised for age.
2 Due to insufficient follow-up time, five-year survival is not available for patients diagnosed during 2005 to 2007.
3 Separate data are not shown for the island NHS boards of Orkney, Shetland and Western Isles due to small populations.
Ref: IR2011-00238.
- Asked by: Rhoda Grant, MSP for Highlands and Islands, Scottish Labour
-
Date lodged: Thursday, 27 January 2011
-
Current Status:
Answered by Nicola Sturgeon on 7 February 2011
To ask the Scottish Executive what the survival rate was for rectal cancer in the periods (a) 1995 to 1999, (b) 2000 to 2002 and (c) 2005 to 2007, broken down by NHS board, and how this compared with the rates in (i) England, (ii) Wales and (iii) Northern Ireland.
Answer
Comparative survival for rectal cancer within the United Kingdom is shown in the following table. It is important to note that survival depends on many factors, including data quality, characteristics of the patients and their tumours (case-mix), and health service factors. Survival estimates are also subject to random variation, especially when based on relatively small numbers of patients.
Cancer of the Rectum and Rectosigmoid Junction (ICD-10 C19-C20)
Relative Survival1 (%) at 1 and 5 Years Following Diagnosis for those Diagnosed Aged 15 to 99 in 1995 to 1999, 2000 to 2002 and 2005 to 20072
| Country/Region | Diagnosed 1995 to 1999 | Diagnosed 2000 to 2002 | Diagnosed 2005 to 2007 |
| 1 Year | 5 Year | 1 Year | 5 Year | 1 Year |
| Scotland | 75.0 | 51.7 | 79.1 | 55.2 | 78.4 |
| NHS Board Areas3 | | | | | |
| Ayrshire and Arran | 80.3 | 57.5 | 81.8 | 57.5 | 73.8 |
| Borders | 74.5 | 47.1 | 78.9 | 47.4 | 83.1 |
| Dumfries and Galloway | 75.1 | 53.5 | 83.6 | 56.2 | 76.6 |
| Fife | 73.0 | 51.9 | 76.6 | 54.0 | 82.3 |
| Forth Valley | 79.7 | 47.9 | 74.1 | 56.8 | 79.5 |
| Grampian | 78.8 | 55.4 | 86.8 | 62.9 | 79.7 |
| Greater Glasgow and Clyde | 71.3 | 49.0 | 77.9 | 52.9 | 74.1 |
| Highland and Argyll | 76.2 | 55.8 | 83.2 | 64.5 | 78.1 |
| Lanarkshire | 73.7 | 46.2 | 72.5 | 46.1 | 79.6 |
| Lothian | 76.9 | 56.7 | 76.1 | 53.1 | 80.3 |
| Tayside | 71.9 | 47.2 | 81.5 | 57.9 | 82.6 |
| England | 74.3 | 50.6 | 76.7 | 54.3 | 78.4 |
| Wales | 72.2 | 47.9 | 76.1 | 51.7 | 78.7 |
| Great Britain | 74.3 | 50.6 | 76.9 | 54.2 | 78.4 |
| Northern Ireland | 77.0 | 48.7 | 79.2 | 53.4 | 82.2 |
| United Kingdom | 74.3 | 50.5 | 76.9 | 54.2 | 78.5 |
Source: UK Cancer Information Service of the National Cancer Intelligence Network.
Notes:
1 The relative survival estimates shown above are adjusted for background mortality in each of the UK countries but not for differences in overall life expectancy in the NHS boards in Scotland (because life tables for NHS boards are not readily available). The survival estimates are not standardised for age or sex.
2 Due to insufficient follow-up time, five-year survival is not available for patients diagnosed during 2005 to 2007.
3 Separate data are not shown for the island NHS boards of Orkney, Shetland and Western Isles due to small populations.
Ref: IR2011-00239.
- Asked by: Rhoda Grant, MSP for Highlands and Islands, Scottish Labour
-
Date lodged: Thursday, 27 January 2011
-
Current Status:
Answered by Nicola Sturgeon on 7 February 2011
To ask the Scottish Executive whether the three pilot programmes in three NHS board areas focussing on patient experiences of cancer services has reported and, if so, whether the results have been published.
Answer
The three experience-based design cancer pilots have not yet formally reported. Each pilot will report at the end of three years, with NHS Glasgow and Greater Clyde and NHS Lothian completing in March 2012 and NHS Grampian in September 2012. Ongoing progress reports are provided by each pilot project at board level and brief six monthly progress reports are provided to the Better Together Programme.
An interim evaluation report will be published by the Better Together Programme in March 2011, sharing the key transferable learning messages to date across the three pilots. A summary of this report will also be provided to the Living with Cancer Programme meeting on 17 March 2011, which in turn will be reported to the Scottish Cancer Taskforce meeting in May 2011
- Asked by: Rhoda Grant, MSP for Highlands and Islands, Scottish Labour
-
Date lodged: Thursday, 27 January 2011
-
Current Status:
Answered by Nicola Sturgeon on 7 February 2011
To ask the Scottish Executive what progress has been made in achieving the same-day surgery target.
Answer
Significant progress has been made against the same day surgery target by all NHS boards over the last year. Performance against the target is 80% overall for NHSScotland at March 2010.
- Asked by: Rhoda Grant, MSP for Highlands and Islands, Scottish Labour
-
Date lodged: Thursday, 27 January 2011
-
Current Status:
Answered by Nicola Sturgeon on 7 February 2011
To ask the Scottish Executive what initiatives are in place to raise awareness of the signs and symptoms of (a) lung, (b) breast, (c) colon, (d) rectal, (e) ovarian and (f) bowel cancer.
Answer
Through the Scottish Cancer Taskforce, the Scottish Government is working to improve awareness of possible signs and symptoms of all cancers amongst the public and amongst medical staff.
To support GPs to identify and recognise possible cancer symptoms and refer patients with suspected cancer as early as possible, referral guidance was published in 2007, called the Scottish Executive Health Department Letter (2007) 9: Scottish Referral Guidelines for Suspected Cancer, which is available on the Scottish Government website at:
www.scotland.gov.uk/quickreferenceguide/suspectedcancer.
A wide range of awareness initiatives are delivered across Scotland, for many different types of cancer, by voluntary, healthcare and social work providers. The Scottish Government recognises the valuable contribution made by these organisations in providing information and advice about cancer signs and symptoms.
- Asked by: Rhoda Grant, MSP for Highlands and Islands, Scottish Labour
-
Date lodged: Thursday, 27 January 2011
-
Current Status:
Answered by Nicola Sturgeon on 7 February 2011
To ask the Scottish Executive what the survival rate was for lung cancer in the periods (a) 1995 to 1999, (b) 2000 to 2002 and (c) 2005 to 2007, broken down by NHS board, and how this compared with the rates in (i) England, (ii) Wales and (iii) Northern Ireland.
Answer
Comparative survival for lung cancer within the United Kingdom is shown in the following table. It is important to note that survival depends on many factors, including data quality, characteristics of the patients and their tumours (case-mix), and health service factors. Survival estimates are also subject to random variation, especially when based on relatively small numbers of patients.
Cancer of the Trachea, Bronchus and Lung (ICD-10 C33-C34)
Relative survival1 (%) at 1 and 5 years Following Diagnosis for those Diagnosed Aged 15 to 99 in 1995 to 1999, 2000 to 2002 and 2005 to 20072
| Country/Region | Diagnosed 1995 to 1999 | Diagnosed 2000 to 2002 | Diagnosed 2005 to 2007 |
| 1 Year | 5 Year | 1 Year | 5 Year | 1 Year |
| Scotland | 26.5 | 7.3 | 27.9 | 7.7 | 29.5 |
| NHS Board Areas3 | | | | | |
| Ayrshire and Arran | 22.8 | 5.9 | 24.9 | 5.9 | 27.0 |
| Borders | 24.3 | 7.3 | 35.1 | 15.3 | 34.9 |
| Dumfries and Galloway | 25.0 | 8.1 | 24.7 | 6.7 | 28.4 |
| Fife | 24.5 | 5.4 | 24.2 | 6.7 | 27.8 |
| Forth Valley | 26.3 | 5.8 | 28.0 | 6.7 | 26.5 |
| Grampian | 30.1 | 8.6 | 31.1 | 9.2 | 31.6 |
| Greater Glasgow and Clyde | 25.3 | 6.9 | 27.5 | 7.2 | 28.3 |
| Highland and Argyll | 30.3 | 9.7 | 24.8 | 7.3 | 28.3 |
| Lanarkshire | 24.8 | 7.2 | 25.8 | 8.2 | 29.3 |
| Lothian | 28.3 | 8.1 | 30.9 | 8.4 | 33.5 |
| Tayside | 29.9 | 7.4 | 29.5 | 6.6 | 30.3 |
| England | 24.8 | 7.2 | 27.2 | 7.7 | 29.3 |
| Wales | 21.9 | 6.6 | 24.9 | 7.0 | 27.3 |
| Great Britain | 24.8 | 7.2 | 27.2 | 7.7 | 29.2 |
| Northern Ireland | 26.6 | 8.7 | 27.0 | 8.5 | 29.3 |
| United Kingdom | 24.9 | 7.2 | 27.2 | 7.7 | 29.2 |
Source: UK Cancer Information Service of the National Cancer Intelligence Network.
Notes:
1 The relative survival estimates shown above are adjusted for background mortality in each of the UK countries but not for differences in overall life expectancy in the NHS boards in Scotland (because life tables for NHS boards are not readily available). The survival estimates are not standardised for age or sex.
2 Due to insufficient follow-up time, five-year survival is not available for patients diagnosed during 2005 to 2007.
3 Separate data are not shown for the island NHS boards of Orkney, Shetland and Western Isles due to small populations.
Ref: IR2011-00245.
- Asked by: Rhoda Grant, MSP for Highlands and Islands, Scottish Labour
-
Date lodged: Thursday, 27 January 2011
-
Current Status:
Answered by Nicola Sturgeon on 7 February 2011
To ask the Scottish Executive what the survival rate was for colon cancer in the periods (a) 1995 to 1999, (b) 2000 to 2002 and (c) 2005 to 2007, broken down by NHS board, and how this compared with the rates in (i) England, (ii) Wales and (iii) Northern Ireland.
Answer
Comparative survival for colon cancer within the United Kingdom is shown in the following table. It is important to note that survival depends on many factors, including data quality, characteristics of the patients and their tumours (case-mix), and health service factors. Survival estimates are also subject to random variation, especially when based on relatively small numbers of patients.
Cancer of the Colon (ICD-10 C18)
Relative Survival1 (%) at 1 and 5 years Following Diagnosis for those Diagnosed Aged 15 to 99 in 1995 to 1999, 2000 to 2002 and 2005 to 20072
| Country/Region | Diagnosed 1995 to 1999 | Diagnosed 2000 to 2002 | Diagnosed 2005 to 2007 |
| 1 Year | 5 Year | 1 Year | 5 Year | 1 Year |
| Scotland | 69.8 | 51.4 | 71.7 | 54.8 | 73.3 |
| NHS Board Areas3 | | | | | |
| Ayrshire and Arran | 74.2 | 49.4 | 71.3 | 54.5 | 70.1 |
| Borders | 64.5 | 47.0 | 71.3 | 50.6 | 66.1 |
| Dumfries and Galloway | 64.4 | 47.8 | 74.1 | 56.6 | 73.6 |
| Fife | 70.4 | 52.3 | 76.8 | 63.1 | 72.0 |
| Forth Valley | 71.6 | 53.7 | 68.6 | 48.9 | 71.4 |
| Grampian | 76.2 | 58.5 | 79.2 | 63.6 | 75.5 |
| Greater Glasgow and Clyde | 67.0 | 48.9 | 68.8 | 50.3 | 73.4 |
| Highland and Argyll | 74.9 | 59.9 | 75.8 | 57.7 | 76.1 |
| Lanarkshire | 66.6 | 44.9 | 65.8 | 44.8 | 70.9 |
| Lothian | 70.5 | 54.4 | 72.6 | 58.2 | 76.3 |
| Tayside | 67.6 | 48.7 | 67.6 | 53.3 | 73.0 |
| England | 67.2 | 48.6 | 68.8 | 51.1 | 71.4 |
| Wales | 64.1 | 46.1 | 67.6 | 50.1 | 69.0 |
| Great Britain | 67.3 | 48.8 | 69.1 | 51.4 | 71.5 |
| Northern Ireland | 70.7 | 52.9 | 73.9 | 55.2 | 72.1 |
| United Kingdom | 67.4 | 48.9 | 69.2 | 51.6 | 71.5 |
Source: UK Cancer Information Service of the National Cancer Intelligence Network.
Notes:
1 The relative survival estimates shown above are adjusted for background mortality in each of the UK countries but not for differences in overall life expectancy in the NHS boards in Scotland (because life tables for NHS boards are not readily available). The survival estimates are not standardised for age or sex.
2 Due to insufficient follow-up time, five-year survival is not available for patients diagnosed during 2005 to 2007.
3 Separate data are not shown for the island NHS boards of Orkney, Shetland and Western Isles due to small populations.
Ref: IR2011-00240.
- Asked by: Rhoda Grant, MSP for Highlands and Islands, Scottish Labour
-
Date lodged: Thursday, 27 January 2011
-
Current Status:
Answered by Nicola Sturgeon on 7 February 2011
To ask the Scottish Executive what the survival rate was for bowel cancer in the periods (a) 1995 to 1999, (b) 2000 to 2002 and (c) 2005 to 2007, broken down by NHS board, and how this compared with the rates in (i) England, (ii) Wales and (iii) Northern Ireland.
Answer
Comparative survival for bowel cancer within the United Kingdom is shown in the following table. It is important to note that survival depends on many factors, including data quality, characteristics of the patients and their tumours (case-mix), and health service factors. Survival estimates are also subject to random variation, especially when based on relatively small numbers of patients.
Colorectal Cancer (ICD-10 C18-C20)
Relative Survival1 (%) at 1 and 5 Years Following Diagnosis for those Diagnosed Aged 15 to 99 in 1995 to 1999, 2000 to 2002 and 2005 to 20072
| Country/Region | Diagnosed 1995 to 1999 | Diagnosed 2000 to 2002 | Diagnosed 2005 to 2007 |
| 1 Year | 5 Year | 1 Year | 5 Year | 1 Year |
| Scotland | 71.6 | 51.5 | 74.3 | 55.0 | 75.1 |
| NHS Board Areas3 | | | | | |
| Ayrshire and Arran | 76.4 | 52.4 | 74.8 | 55.6 | 71.3 |
| Borders | 68.0 | 47.0 | 74.1 | 49.3 | 73.2 |
| Dumfries and Galloway | 68.7 | 50.2 | 77.7 | 56.5 | 74.8 |
| Fife | 71.4 | 52.2 | 76.7 | 59.9 | 75.9 |
| Forth Valley | 74.6 | 51.6 | 70.4 | 51.6 | 74.1 |
| Grampian | 77.1 | 57.4 | 81.8 | 63.4 | 76.9 |
| Greater Glasgow and Clyde | 68.4 | 48.9 | 71.9 | 51.2 | 73.6 |
| Highland and Argyll | 75.3 | 58.7 | 78.2 | 59.9 | 76.8 |
| Lanarkshire | 69.2 | 45.4 | 68.3 | 45.3 | 73.9 |
| Lothian | 72.7 | 55.2 | 73.8 | 56.4 | 77.7 |
| Tayside | 69.1 | 48.2 | 72.2 | 54.9 | 76.6 |
| England | 69.9 | 49.4 | 71.8 | 52.3 | 74.1 |
| Wales | 67.1 | 46.8 | 70.8 | 50.7 | 72.6 |
| Great Britain | 69.9 | 49.4 | 72.0 | 52.5 | 74.1 |
| Northern Ireland | 72.7 | 51.5 | 75.8 | 54.6 | 75.5 |
| United Kingdom | 70.0 | 49.5 | 72.1 | 52.6 | 74.1 |
Source: UK Cancer Information Service of the National Cancer Intelligence Network.
Notes:
1 The relative survival estimates shown above are adjusted for background mortality in each of the UK countries but not for differences in overall life expectancy in the NHS boards in Scotland (because life tables for NHS boards are not readily available). The survival estimates are not standardised for age or sex.
2 Due to insufficient follow-up time, five-year survival is not available for patients diagnosed during 2005-2007.
3 Separate data are not shown for the island NHS boards of Orkney, Shetland and Western Isles due to small populations.
Ref: IR2011-00237.
